Kevin Bitterman's most recent trade in Disc Medicine Inc was a trade of 222,223 Common Stock done at an average price of $36 . Disclosure was reported to the exchange on June 17, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Disc Medicine Inc | Kevin Bitterman | Director | Purchase of securities on an exchange or from another person at price $ 36.00 per share. | 17 Jun 2024 | 222,223 | 420,549 | - | 36 | 8,000,028 | Common Stock |
Disc Medicine Inc | Kevin Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 73.50 per share. | 05 Mar 2024 | 26,157 | 677,503 | - | 73.5 | 1,922,540 | Common Stock |
Disc Medicine Inc | Bitterman Kevin | Director | Sale of securities on an exchange or to another person at price $ 67.65 per share. | 23 Jan 2024 | 82,500 | 703,660 | - | 67.7 | 5,581,125 | Common Stock |
Disc Medicine Inc | Bitterman Kevin | Director | Sale of securities on an exchange or to another person at price $ 67.65 per share. | 23 Jan 2024 | 20,000 | 198,326 | - | 67.7 | 1,353,000 | Common Stock |
Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 64.00 per share. | 10 Jan 2024 | 20,000 | 786,160 | - | 64 | 1,280,000 | Common Stock |
Disc Medicine Inc | Bitterman Kevin | Director | Sale of securities on an exchange or to another person at price $ 59.87 per share. | 12 Dec 2023 | 20,823 | 861,401 | - | 59.9 | 1,246,673 | Common Stock |
Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 58.27 per share. | 12 Dec 2023 | 20,429 | 806,280 | - | 58.3 | 1,190,398 | Common Stock |
Disc Medicine Inc | Bitterman Kevin | Director | Sale of securities on an exchange or to another person at price $ 65.10 per share. | 12 Dec 2023 | 18,615 | 836,856 | - | 65.1 | 1,211,837 | Common Stock |
Disc Medicine Inc | Bitterman Kevin | Director | Sale of securities on an exchange or to another person at price $ 65.77 per share. | 12 Dec 2023 | 6,599 | 830,257 | - | 65.8 | 434,016 | Common Stock |
Disc Medicine Inc | Bitterman Kevin | Director | Sale of securities on an exchange or to another person at price $ 62.42 per share. | 12 Dec 2023 | 4,155 | 856,824 | - | 62.4 | 259,355 | Common Stock |
Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 59.99 per share. | 12 Dec 2023 | 3,508 | 826,749 | - | 60.0 | 210,445 | Common Stock |
Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 63.78 per share. | 12 Dec 2023 | 688 | 855,471 | - | 63.8 | 43,881 | Common Stock |
Disc Medicine Inc | Bitterman Kevin | Director | Sale of securities on an exchange or to another person at price $ 62.90 per share. | 12 Dec 2023 | 665 | 856,159 | - | 62.9 | 41,829 | Common Stock |
Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 60.99 per share. | 12 Dec 2023 | 422 | 860,979 | - | 61.0 | 25,738 | Common Stock |
Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 59.74 per share. | 12 Dec 2023 | 120 | 806,160 | - | 59.7 | 7,169 | Common Stock |
Disc Medicine Inc | Bitterman Kevin | Director | Sale of securities on an exchange or to another person at price $ 60.50 per share. | 12 Dec 2023 | 40 | 826,709 | - | 60.5 | 2,420 | Common Stock |
Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 52.40 per share. | 15 Aug 2023 | 72,931 | 882,224 | - | 52.4 | 3,821,584 | Common Stock |
Disc Medicine Inc | Kevin Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 7,136 | 7,136 | - | - | Stock Option (Right to Buy) | |
Disc Medicine Inc | Kevin Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2022 | 7,000 | 7,000 | - | - | Stock Option (Right to Buy) | |
Akero Therapeutics Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 26.28 per share. | 01 Jun 2021 | 16,544 | 0 (0%) | 0% | 26.3 | 434,776 | Common Stock |
Akero Therapeutics Inc | Kevin Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
Akero Therapeutics Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 26.28 per share. | 01 Jun 2021 | 945 | 0 (0%) | 0% | 26.3 | 24,835 | Common Stock |
Akero Therapeutics Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 28.93 per share. | 09 Oct 2020 | 13,000 | 11,780 (0%) | 0% | 28.9 | 376,090 | Common Stock |
Akero Therapeutics Inc | Kevin Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) |